Positive Developments for Treating Patients With Recurrent Malignant Tumors Significant for Novel Therapeutic Strategies

PALM BEACH, Florida, November 1, 2018 /PRNewswire/ -- Financialnewsmedia.com News Commentary Multiple myeloma (MM) known as a plasma cell malignancy that affects 14,000 patients per year are fueling the development and clinical activities for new therapies to treat these...

from PR Newswire: //https://ift.tt/2qmhz0P